INTRODUCTION
Gastric cancer is still a major health problem and leading cause of cancer death in spite of decreasing worldwide incidence. About one million new cases of stomach cancer were estimated to have occurred in 2008 (988,000 cases, 7.8% of the total cancer), making it the fourth most common malignancy in the world. Moreover, stomach cancer is the second leading cause of cancer death in both sexes worldwide (736,000 deaths a year, 9.7% of the total) [1] .
Gastric cancer is also the most common cancer and annually affects over 25,000 patients in Korea, where the incidence is stationary or slightly decreased. In addition, it is the second leading cause of cancer death after lung cancer, thesurgery.or.kr and is up to over 10,000 deaths a year [2, 3] . There are notable changes over the past 20 years. The proportion of early gastric cancer (EGC) and proximal gastric cancer has increased continuously from 24.8 to nearly 50% and from 5.3 to 14.0%, respectively. Proximal EGC consisted of 30.3% of total proximal gastric cancer while distal EGC consisted of 51.5% of total distal gastric cancer [4, 5] . There is also increasing trend of older gastric cancer patients due to in- 
LAPAROSCOPIC GASTRECTOMY IN DIS-TAL EGC
Considering the excellent prognosis of EGC, the quality of life after operation has been focused on these patients.
For the better quality of life, laparoscopic gastrectomy has emerged as an alternative treatment option for EGC . If the result of these two trials will be positive, the laparoscopic gastrectomy will be a standard method for distally located EGC like the clinical outcomes of surgical therapy (COST) study group trial did in colon cancer [16] .
In the view of laparoscopic techniques for distal gastric cancer, there are some trends of moving from extra-corporeal anastomosis to an intra-corporeal fashion to get rid of mini-laparotomy for improving the quality of life of patients. Totally laparoscopic distal gastrectomy (TLDG) with delta-shape anastomosis is a representative procedure. In one retrospective study, it was suggested that TLDG contributes to the improvement of early surgical outcomes, more interestingly, TLDG in obese patients could be the best way to improve early surgical outcomes, including the bowel movement, pain score, overall complication rate [17] . In another study which was prospective, non-randomized with small numbers of cases, no significant difference was found in mean operative Table 2 . Six prospective randomized controlled trials about laparoscopy-assisted distal gastrectomy for gastric cancer time, estimated blood loss, or immunologic or inflammatory markers between TLDG and LADG. However, time to first meal was significantly shorter in the TLDG group than either LADG or ODG but TLDG needed more cost [18] . Intra-corporeal anastomosis without mini-laparotomy is gaining more popularity. However, to prove superiority of this procedure over LADG, phase III trials are required.
In the aspect of reconstruction methods, the Billroth I procedure was most frequently performed after distal gastrectomy (63. proposed mechanism is that by bypassing duodenum and proximal jejunum, loss of the signals causing insulin resistance is achieved (foregut hypothesis) and fast reach to hindgut cause early signal for glucose control (hindgut hypothesis) [20] . In the patients of gastric cancer with type 2 diabetes and high body mass index, Roux-en-Y gastrojejunostomy method is expected to be better than Billroth I methods to resolve type 2 diabetes and obesity [21] . In one study from Japan, they reported that Roux-en-Y reconstruction after distal gastrectomy seems superior to Billroth-I reconstruction for preventing both bile reflux into the gastric remnant and postoperative complications.
They concluded R-Y reconstruction was a feasible and safe method for LADG [22] . 
LAPAROSCOPIC FUNCTION PRESERVING GASTRECTOMY

LAPAROSCOPY-ASSISTED TOTAL GAST-RECTOMY
LATG remains challenging under the laparoscopic approach and the technique has not been standardized. The incidence of complications is reported to be higher comparing with LADG, and a reliable method of esophago-jejunostomy is still key issues [33] . In our retrospective study, which was a relatively large number of cases, comparative analysis of short-term outcomes between extracorporeal end-to-side E-Jstomy and intracorporeal side-to-side E-Jstomy was done. We concluded by this study that end-to-side E-Jstomy using circular stapler could be recommended after LATG because E-Jstomy leakage rates (14.3% vs. 2.2%, P = 0.043) after side-to-side E-Jstomy by linear stapler & intracorporeal suture was higher than end-to-side E-Jstomy [37] . Based on these results, we changed the anastomosis methods to intracorporeal end-to-side E-Jstomy using by laparoscopic purse-string clamp (LapJack, Eterne) and circular stapler. After the application of LapJack, there has been no anastomotic problems, including leakage, in the consecutive 50 cases, which is very promising.
However, the optimal procedures for reconstruction methods after LATG have yet to be established [36] . And there have been a few reports on this subject. We need more advanced, novel instruments such as deployable stapler and techniques for the application for LATG or totally laparoscopic total gastrectomy.
LAPAROSCOPIC SURGERY FOR AGC
Open surgery has been the standard method for AGC for over 100 years. There are no evidences of the application of laparoscopic approach in AGC at present. Technical feasibility of laparoscopy gastrectomy for AGC largely depends on the applicability and safety of D2 lymph node dissection, which is regarded as a standard for AGC in Korea and Japan. Recently, several experienced surgeons have tried to extend the application of laparoscopy-assisted gastrectomy for AGC. In some studies, the shortterm and the long-term outcomes after laparoscopy-assisted gastrectomy for AGC were non-inferior to open surgery. But these were small size, retrospective studies with many biases [38, 39] . One RCT and one retrospective case controlled study including advanced gastric cancer showed that there was no significant difference between two groups in terms of the number of resected lymph nodes, recurrence and survival [7, 40] . One retrospective single center study demonstrated that five-year overall survival rate was 81.4% [41] . These retrospective data has selection bias that preoperative stage was cT2 or less than cT2 but final pathologic stage was T2 or more than T2. of gastric cancer [42] . In one large prospective multicenter trial of sentinel node mapping for gastric cancer, Kitagawa et al [43] . reported at ASCO in 2009 that the detection rates was 97.5% (387/397), the mean numbers of SNs 5.6 and the sensitivity and the accuracy was 93% (53/57) and 99% (383/ 387), respectively. There were 4 cases of false-negative cases; among them, 2 cases were T2 and 3 cases were on same basin. Their eligible criteria were that patients had clinically T1-2N0M0 single tumor with diameter of primary lesion less than 4 cm without any previous treatment.
SNNS IN LAPAROSCOPIC ERA
They used radioactive tin colloid and isosulfan blue for dual traces.
In our series, we initially used indocyanine green and Tc-ASC (simultaneous injections in the second phase, n = 52) (Fig. 1) . The SNs were identified in 62 of the 68 patients (91.2%; mean 3.3 per patient) with gastric cancer, and the sensitivity and specificity of SNNS was elevated to 100% by using the dual dye methods and basin dissection. If there are no metastasis in SNs in basins, no further dissection is necessary, which means that the hepatic and celiac branch of vagus nerve and parasympathetic nerve to small bowel can be saved, so it guarantee gastric and small bowel motility function [44] . In the near future, most of EGC patients will be treated by one-stop intraoperative endoscopic submucosal dissection plus SNNS rather than the extensive resection and lymph node dissection in the way modified radical mastectomy with axillary lymph node dissection has migrated to the lumpectomy with SNNS in breast cancer [44] . pital stay were significantly less than in the robotic group, the operative time was significantly longer. Furthermore, with respect to performing D2 lymphadenectomy, surgeons found the dissection around major vessels to be easier robotically due to the stability of the camera, the articulation of the operating arms, and the 3-D, magnified view [45] .
ROBOTIC SURGERY IN GASTRIC CANCER
We must try to identify the beneficial aspects of patients but its cost is too high to study large number of patients.
So, to begin with, we should focus on cost-cutting of current robotic surgery, such as localization of laparoscopic robot to abolish the monopoly of da Vinci. We must lead in the field of robotic gastrectomy and make the evidences of robot gastrectomy by balancing costs with its effectiveness, as there are a few cases of robotic gastrectomy outside Korea. The Multi-institutional prospective study on the assessment of robotic surgery for gastric cancer in Korea is now proceeding according to plan. It is certain that robotic surgery will become an additional option in minimally invasive surgery.
NEW EMERGING TECHNIQUES
Single incision laparoscopic surgery (SILS) was developed to reduce the minimal invasiveness of laparoscopy to an ultra-minimal invasiveness and to achieve excellent cosmesis. The SILS has been performed in various surgeries such as cholecystectomy, appendectomy, colectomy, sleeve gastrectomy for morbid obesity [46, 47] . Very recently, there was the first report on successful single-incision laparoscopic gastrectomy for EGC [48] . They used a vertical 2.5-cm intraumbilical incision with two 2-mm mini-loop retractor. All seven cases with single-incision laparoscopic distal gastrectomies (SIDG) were performed without conversion to LADG or open gastrectomy. The median operative time was 344 minutes (range, 282 to 385 minutes). They showed that SIDG was a feasible and safe procedure for EGC and gives a favorable cosmetic result.
Further research is warranted to evaluate the safety and feasibility of SIDG. Our team also had the experiences of two SIDG cases followed by experimental study "SIDG vs.
LADG in a porcine model" which is going to be published soon. Eventually, after further development of smart instruments with 5-mm flexible scopes, which could possibly be used in single port, for example, it will be the time that SILS become the optional treatment for gastric cancer.
It currently remains in experimental stages.
Natural Orifice Transluminal Endoscopic Surgery has increasingly been reported as the future new technique to laparoscopic surgery. A few reports have emerged reporting a hybrid approach using transvaginal NOTES technique with laparoscopic assistance in the partial gastrectomy of submucosal tumor, with removal of the specimen through the vagina [49] . Several proposals for transgastric resection or lymph node biopsy or dissection have also been proposed via NOTES technique [50] . But there are many criticisms of this proposal for which oncologic safety needs to be considered. There is no role for NOTES for gastric cancer yet.
CONCLUSION
Gastric cancer treatment is now moving on to a new era. 
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